Buclizine
Back to searchMolecule Structure
Scientific Name
Buclizine
Description of the Drug
Buclizine is an antihistamine and antiemetic drug for the treatment of allergy symptoms and prevention of nausea and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00354
http://www.drugbank.ca/drugs/DB00354
Brand Name(s)
Not Available
Company Owner(s)
Stuart Pharmaceuticals Div Ici Americas
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL27855 | |
PharmGKB | PA164748223 | |
Human Metabolome Database | HMDB0014498 | |
DrugBank | DB00354 | |
PubChem: Thomson Pharma | 14982780 | |
PubChem | 6729 | |
Nikkaji | J4.623J | |
EPA CompTox Dashboard | DTXSID0022694 | |
DrugCentral | 416 | |
ChemicalBook | CB9111794 | |
Guide to Pharmacology | 7134 | |
rxnorm | BUCLIZINE | BUCLIZINE HYDROCHLORIDE |
KEGG Ligand | C07777 | |
ChEBI | 3205 |